nafamostat has been researched along with Invasiveness, Neoplasm in 3 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Excerpt | Relevance | Reference |
---|---|---|
" Nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor, inhibited liver metastasis in a CDF1 mice model with colon 26 adenocarcinoma cells." | 3.68 | Inhibitory effect of nafamostat mesilate on metastasis into the livers of mice and on invasion of the extracellular matrix by cancer cells. ( Fuchimoto, S; Hizuta, A; Iwagaki, H; Kimura, T; Orita, K, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, Y | 1 |
Furukawa, K | 1 |
Haruki, K | 1 |
Shimada, Y | 1 |
Iida, T | 1 |
Shiba, H | 1 |
Uwagawa, T | 1 |
Ohashi, T | 1 |
Yanaga, K | 1 |
Yamashita, Y | 1 |
Ishiguro, Y | 1 |
Sano, D | 1 |
Kimura, M | 1 |
Fujita, K | 1 |
Yoshida, T | 1 |
Horiuchi, C | 1 |
Taguchi, T | 1 |
Matsuda, H | 1 |
Mikami, Y | 1 |
Tsukuda, M | 1 |
Kimura, T | 1 |
Fuchimoto, S | 1 |
Iwagaki, H | 1 |
Hizuta, A | 1 |
Orita, K | 1 |
3 other studies available for nafamostat and Invasiveness, Neoplasm
Article | Year |
---|---|
Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
Topics: Animals; Benzamidines; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Enzym | 2011 |
Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; Benzamidines; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cell | 2007 |
Inhibitory effect of nafamostat mesilate on metastasis into the livers of mice and on invasion of the extracellular matrix by cancer cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antithrombins; Benzamidines; Colonic Neoplasms; Extr | 1992 |